Drug-drug interactions and potentially inappropriate medications among elderly outpatients

Authors

  • Atrianfar Fatemeh Faculty of pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Rezaei Fatemeh Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
  • Heidari Kazem Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
  • Kargar Mona Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran https://orcid.org/0000-0002-2572-4991
  • Javadi Mohammad Reza Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
  • Gholam Kheirollah Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.1590/s2175-97902020000418728

Keywords:

Elderly. Zhan criteria. Drug Interactions. Potentially Inappropriate Medication.

Abstract

The high prevalence of concomitant chronic illnesses and the resulting higher number of medications in the elderly population increase the risk of adverse drug reactions due to drug-drug interactions (DDIs) and potentially inappropriate medications (PIMs). Therefore, the aim of this study was to investigate the prevalence and factors associated with DDIs and PIMs in outpatient geriatrics. In this cross-sectional study, 1512 prescriptions belonging to patients aged ≥65 years from five public pharmacies in Tehran were evaluated. Clinically relevant (C, D, and X) and significant DDIs (D and X) were documented according to the Lexicomp®. Additionally, Zhan criteria were used to detect PIMs. At least one clinically relevant DDI was detected in 61.7% of the prescriptions containing ≥2 medications. The largest percentage of prescriptions with DDIs was prescribed by cardiologists (74.3%). The number of medications in prescriptions and the specialty of the prescriber significantly affected both clinically relevant and significant DDIs in a logistic regression model. At least one PIM was identified in 16.3% of the prescriptions. General practitioners (GPs) were the largest prescribers of PIMs. The mean number of medications was significantly higher in prescriptions with PIMs. In conclusion, clinically relevant DDIs are frequent in the elderly. In terms of PIMs, more attention should be paid to the education of GPs.

Downloads

Download data is not yet available.

References

Ahmadizar F, Soleymani F, Abdollahi M. Study of drug-drug interactions in prescriptions of general practitioners and specialists in Iran 2007-2009. Iran J Pharm Res. 2011;10(4):921-931

Azoulay L, Zargarzadeh A, Salahshouri Z, Oraichi D, Bérard A. Inappropriate medication prescribing in community-dwelling elderly people living in Iran. Eur J Clin Pharmacol. 2005;61(12):913-919.

Barnett MJ, Perry PJ, Langstaff JD, Kaboli PJ. Comparison of rates of potentially inappropriate medication use according to the Zhan criteria for VA versus private sector medicare HMOs. J Manag Care Pharm. 2006;12(5):362-370.

Basnet S, Paudel KR, Sah AK, Jha RK, Sah P, Adhikari S, Shrestha S. Prescribing pattern, polypharmacy and potentially inappropriate prescribing in hospitalized elderly patients: a retrospective study in a teaching hospital in Nepal. Int J Sci Rep. 2016;2(1):7-12.

Bazargan M, Yazdanshenas H, Han S, Orum G. Inappropriate medication use among underserved elderly African Americans. J Aging Health. 2016;28(1):118-138.

Buck MD, Atreja A, Brunker CP, Jain A, Suh TT, Palmer RM, Dorr DA, Harris CM, Wilcox AB. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records. Am J Geriatr Pharmacother. 2009;7(2):84-92.

Dirin MM, Mousavi S, Afshari AR, Tabrizian K, Ashrafi MH. Potential drug-drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran. J Res Pharm Pract. 2014;3(3):104-107

Fadare JO, Ajayi AE, Adeoti AO, Desalu OO, Obimakinde AM, Agboola SM. Potential drug-drug interactions among elderly patients on anti-hypertensive medications in two tertiary healthcare facilities in Ekiti State, South-West Nigeria. Sahel Med J. 2016;19(1):32-37

Ghadimi H, Esmaily HM, Wahlstrom R. General practitioners' prescribing patterns for the elderly in a province of Iran. Pharmacoepidemiol Drug Saf. 2011;20(5):482-487.

Gnjidic D, Johnell K. Clinical implications from drug-drug and drug-disease interactions in older people. Clin Exp Pharmacol Physiol.2013;40(5):320-325.

Gören Z, Demirkapu Mj, Acet Ga, Cali S, Oglu Mgi. Potential drug-drug interactions among prescriptions for elderly patients in primary health care. Turk J Med Sci. 2017;47(1):47-54.

Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164(3):305-312.

Hersh LR, Beldowski K, Hajjar ER. Polypharmacy in the geriatric oncology population. Curr Oncol Rep. 2017;19(11):73.

Jazbar J, Locatelli I, Horvat N, Kos M. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study. Res Social Adm Pharm. 2018;14(6):572-580

Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly. Drug Safety. 2007;30(10):911-918.

Juárez-Cedillo T, Martinez-Hernández C, Hernández-Constantino A, Garcia-Cruz JC, Mariso A. Clinical Weighting of Drug-Drug Interactions in Hospitalized Elderly. Basic Clin Pharmacol Toxicol. 2016;118(4):298-305

Lao CK, Chan KK, Tou CF, Tong HHY, Chan A. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao. Int J Clin Pharm. 2013;35(5):805-812.

Lexicomp(r) OnlineTM user guide Available from: https://online.lexi.com/lco/help/lco-ug.pdf

» https://online.lexi.com/lco/help/lco-ug.pdf

Lin CF, Wang CY, Bai CH. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan. a retrospective computerized screening study. Drugs Aging. 2011;28(3):219-225.

Marusic S, Bacic-Vrca V, Neto PRO, Franic M, Erdeljic V, Gojo-Tomic N. Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study. Eur J Clin Pharmacol. 2013;69(9):1717-1724.

Nabovati E, Vakili-Arki H, Taherzadeh Z, Hasibian MR, Abu-Hanna A, Eslami S. Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature. Daru. 2014, 25;22:52.

Nabovati E, Vakili-Arki H, Taherzadeh Z, Saberi MR, Abu-Hanna A, Eslami S. Incidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country. Res Pharm Sci. 2016;11(3):233-242

Nabovati E, Vakili-Arki H, Taherzadeh Z, Saberi MR, Abu-Hanna A, Eslami S. A survey of attitudes, practices, and knowledge regarding drug-drug interactions among medical residents in Iran. Int J Clin Pharm. 2017;39(3):560-568.

Neto PRO, Nobili A, Marusic S, Pilger D, Guidoni CM, de Oliveira Baldoni A, Cruciol-Souza JM, da Cruz AN, Gaeti WP, Cuman RKN. Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the brazilian primary public health system. J Pharm Pharm Sci. 2012;15(2):344-354.

Novaes PH, da Cruz DT, Lucchetti ALG, Leite ICG, Lucchetti G. The "iatrogenic triad": polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults. Int J Clin Pharm. 2017;39(4):818-825.

Kargar M, Atrianfar F, Rashidian A, Heidari K, Noroozian M, Gholami Kh et al. Prescribing for geriatrics in Tehran; is it appropriate and rational?. Med J Islam Repub Iran. 2019; 33 (143). doi: 10.34171/mjiri.33.143.

» https://doi.org/10.34171/mjiri.33.143.

Obreli-Neto PR, Nobili A, de Lyra Júnior DP, Pilger D, Guidoni CM, de Oliveira Baldoni A, Cruciol-Souza JM, de Carvalho Freitas AL, Tettamanti M, Gaeti WP. Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. J Pharm Pharm Sci. 2012;15(2):332-343.

Pugh MJV, Fincke BG, Bierman AS, Chang BH, Rosen AK, Cunningham FE, Amuan ME, Burk ML, Berlowitz DR. Potentially inappropriate prescribing in elderly veterans: are we using the wrong drug, wrong dose, or wrong duration? J Am Geriatr Soc. 2005;53(8):1282-1289.

Reis AMM, Cassiani SHDB. Evaluation of three brands of drug interaction software for use in intensive care units. Pharm World Sci. 2010;32(6):822-828.

Rosa ASKC, Costa BP, Kapper CP, Dalmas GGS, Sbroglio LL, Andreis L, Lampert MA. Identification of inappropiate prescribing in a Geriatric outpatient clinic using the Criteria Stopp Start. Rev Bras Geriatr Gerontol. 2016;19(5):871-879.

Salwe KJ, Kalyansundaram D, Bahurupi Y. A study on polypharmacy and potential drug-drug interactions among elderly patients admitted in department of medicine of a tertiary care hospital in Puducherry. J Clin Diagn Res. 2016;10(2): 6-10

Sánchez-Fidalgo S, Guzmán-Ramos MI, Galván-Banqueri M, Bernabeu-Wittel M, Santos-Ramos B. Prevalence of drug interactions in elderly patients with multimorbidity in primary care. Int J Clin Pharm. 2017;39(2):343-353.

Scondotto G, Pojero F, Addario SP, Ferrante M, Pastorello M, Visconti M, Scondotto S, Casuccio A. The impact of polypharmacy and drug interactions among the elderly population in Western Sicily, Italy. Aging Clin Exp Res. 2018;30(1):81-87.

Secoli S-R, Figueras A, Lebrao ML, de Lima FD, Santos JLF. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study. Drugs Aging. 2010;27(9):759-770.

Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in US Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc. 2005;53(2):227-232.

Steele KM, Ruisinger JF, Bates J, Prohaska ES, Melton BL, Hipp S. Home-Based Comprehensive Medication Reviews: Pharmacist's Impact on Drug Therapy Problems in Geriatric Patients. Consult Pharm. 2016;31(10):598-605.

Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Kaboli PJ. Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med. 2009;169(14):1326-1332.

Teka F, Teklay G, Ayalew E, Teshome T. Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study. BMC Res Notes. 2016;9(1):431.

Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging. 2008;25(4):343-355.

Welker KL, Mycyk MB. Pharmacology in the geriatric patient. Emerg Med Clin North Am. 2016;34(3):469-481.

Williams BA, Baillargeon JG, Lindquist K, Walter LC, Covinsky KE, Whitson HE, Steinman MA. Medication prescribing practices for older prisoners in the Texas prison system. Am J Public Health. 2010;100(4):756-761.

World Health Organization. Mental health and older adults. updated December 2017. Available from: http://www.who.int/mediacentre/factsheets/fs381/en/

» http://www.who.int/mediacentre/factsheets/fs381/en/

Zargarzadeh AH, Sadeghi K, Mirmoghtadaei P. Prescribing of Potentially Inappropriate Medications to Elderly People by Medical Specialists in Isfahan, Iran. Iranian Journal of Pharmaceutical Sciences. 2008;4(4):241-6.

Zarif-Yeganeh M, Kargar M, Rashidian A, Jafarzadeh Kohneloo A, Gholami Kh. Out of pocket payment and affordability of medication for geriatric patients in Tehran. Iran J Public Health. 2019;48(6):1124-1132.

Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. Jama. 2001;286(22):2823-2829.

Downloads

Published

2022-11-09

Issue

Section

Original Article

How to Cite

Drug-drug interactions and potentially inappropriate medications among elderly outpatients. (2022). Brazilian Journal of Pharmaceutical Sciences, 57. https://doi.org/10.1590/s2175-97902020000418728

Funding data